ClinicalTrials.Veeva

Menu

Assessment of Admission to the ICU of Onco-hematological Patients.

U

University Hospital A Coruña

Status

Not yet enrolling

Conditions

Critical Illness
Hematological Diseases

Treatments

Other: There is no intervention.

Study type

Observational

Funder types

Other

Identifiers

NCT06113601
23772377

Details and patient eligibility

About

Multicenter, observational and prospective study.

Full description

The data collection period will include 6 consecutive months, starting from the date of acceptance or conformity of the CEIC. Or, until an adequate sample size is reached that guarantees the statistical relevance of said analysis. All patients will subsequently be followed up 3 months after discharge from the ICU.

Enrollment

800 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults
  • Solid organ tumor or hematological malignancy,

Exclusion criteria

-under 18 years old

Trial design

800 participants in 2 patient groups

Patients admitted to the ICU.
Treatment:
Other: There is no intervention.
Patients who are not admitted to the ICU.
Treatment:
Other: There is no intervention.

Trial contacts and locations

0

Loading...

Central trial contact

Elena Cuenca Fito

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems